Neurotrophic factors as novel therapeutics for neuropathic pain

被引:119
作者
Sah, DWY
Ossipov, MH
Porreca, F [1 ]
机构
[1] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA
[2] Biogen Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1038/nrd1107
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Neuropathic pain is a chronic condition that is caused by injury to the nervous system. Unlike acute pain, which is protective, neuropathic pain persists and serves no useful purpose, and severely affects quality of life. However, present therapies have modest efficacy in most patients, are palliative rather than curative, and their side effects represent significant limitations. Tremendous progress has been made over the past decade in our understanding of the biology of pain sensory neurons. The recent discovery that neurotrophic factors play an important role in neuropathic pain indicates that these pathways could serve as novel intervention points for therapy. Moreover, neurotrophic factors have the potential to address the underlying pathophysiology of neuropathic pain, thereby halting or reversing the disease process.
引用
收藏
页码:460 / 472
页数:13
相关论文
共 217 条
[1]   A new member of the acid-sensing ion channel family [J].
Akopian, AN ;
Chen, CC ;
Ding, YN ;
Cesare, P ;
Wood, JN .
NEUROREPORT, 2000, 11 (10) :2217-2222
[2]   Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease [J].
Alberch, J ;
Pérez-Navarro, E ;
Canals, JM .
BRAIN RESEARCH BULLETIN, 2002, 57 (06) :817-822
[3]   Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans [J].
Aley, KO ;
Reichling, DB ;
Levine, JD .
NEUROSCIENCE, 1996, 73 (01) :259-265
[4]  
Andres R, 2001, DEVELOPMENT, V128, P3685
[5]   Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial [J].
Apfel, SC ;
Schwartz, S ;
Adornato, BT ;
Freeman, R ;
Biton, V ;
Rendell, M ;
Vinik, A ;
Giuliani, M ;
Stevens, JC ;
Barbano, R ;
Dyck, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17) :2215-2221
[6]   NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE [J].
APFEL, SC ;
LIPTON, RB ;
AREZZO, JC ;
KESSLER, JA .
ANNALS OF NEUROLOGY, 1991, 29 (01) :87-90
[7]   NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY [J].
APFEL, SC ;
AREZZO, JC ;
LIPSON, L ;
KESSLER, JA .
ANNALS OF NEUROLOGY, 1992, 31 (01) :76-80
[8]   Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy [J].
Apfel, SC ;
Kessler, JA ;
Adornato, BT ;
Litchy, WJ ;
Sanders, C ;
Rask, CA .
NEUROLOGY, 1998, 51 (03) :695-702
[9]   NERVE GROWTH-FACTOR ADMINISTRATION PROTECTS AGAINST EXPERIMENTAL DIABETIC SENSORY NEUROPATHY [J].
APFEL, SC ;
AREZZO, JC ;
BROWNLEE, M ;
FEDEROFF, H ;
KESSLER, JA .
BRAIN RESEARCH, 1994, 634 (01) :7-12
[10]   LACK OF ANALGESIC EFFECT OF OPIOIDS ON NEUROPATHIC AND IDIOPATHIC FORMS OF PAIN [J].
ARNER, S ;
MEYERSON, BA .
PAIN, 1988, 33 (01) :11-23